Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485677 (US10940139, Example 02907 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485674 (US10940139, Example 02900 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485673 (US10940139, Example 02899 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >3.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485654 (US10940139, Example 02511 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485657 (US10940139, Example 02639 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485654 (US10940139, Example 02511 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485654 (US10940139, Example 02511 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485653 (US10940139, Example 02471 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485653 (US10940139, Example 02471 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485657 (US10940139, Example 02639 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485657 (US10940139, Example 02639 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485653 (US10940139, Example 02471 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | <5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485663 (US10940139, Example 02734 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485664 (US10940139, Example 02761 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485666 (US10940139, Example 02769 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485672 (US10940139, Example 02808 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485655 (US10940139, Example 02555 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485658 (US10940139, Example 02647 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485659 (US10940139, Example 02680 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485661 (US10940139, Example 02708 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485663 (US10940139, Example 02734 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485664 (US10940139, Example 02761 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485666 (US10940139, Example 02769 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485672 (US10940139, Example 02808 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I:50 mM Tris, pH 7.5150 mM NaCl (optional)1 mM MgCl21 mM DTT... | Citation and Details BindingDB Entry DOI: 10.7270/Q2FB56SS | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485659 (US10940139, Example 02680 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485658 (US10940139, Example 02647 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485655 (US10940139, Example 02555 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485672 (US10940139, Example 02808 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485666 (US10940139, Example 02769 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485664 (US10940139, Example 02761 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485663 (US10940139, Example 02734 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485661 (US10940139, Example 02708 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485659 (US10940139, Example 02680 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485658 (US10940139, Example 02647 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485655 (US10940139, Example 02555 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | Purchase PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485661 (US10940139, Example 02708 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 7.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485656 (US10940139, Example 02592 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485660 (US10940139, Example 02704 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485662 (US10940139, Example 02726 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485665 (US10940139, Example 02767 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485667 (US10940139, Example 02773 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485668 (US10940139, Example 02799 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485669 (US10940139, Example 02800 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485670 (US10940139, Example 02803 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485671 (US10940139, Example 02804 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485675 (US10940139, Example 02901 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485676 (US10940139, Example 02903 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Shy Therapeutics LLC US Patent | Assay Description Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) 1 mM MgCl2 1 mM DTT. KRas G12D mutant protein was expressed as... | US Patent US11000515 (2021) BindingDB Entry DOI: 10.7270/Q2V98C6R | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485656 (US10940139, Example 02592 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485660 (US10940139, Example 02704 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
GTPase KRas [G12D,Q61H] (Homo sapiens (Human)) | BDBM485662 (US10940139, Example 02726 | US11000515, Compound T...) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 2.05E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA | Assay Description The following method was developed as specific assay for KRas G12D mutant protein.Buffer-I: 50 mM Tris, pH 7.5 150 mM NaCl (optional) ... | Citation and Details BindingDB Entry DOI: 10.7270/Q20G3PBB | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 75 total ) | Next | Last >> |